Steroid-sensitive nephrotic syndrome
Information
- Disease name
- Steroid-sensitive nephrotic syndrome
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04783675 | Completed | Phase 2 | Efficacy and Safety of Rituximab in the First Episode of Pediatric Idiopathic Nephrotic Syndrome | April 13, 2021 | January 17, 2023 |
| NCT05850546 | Not yet recruiting | Phase 3 | Rituximab in the First Episode of Paediatric Nephrotic Syndrome | April 1, 2024 | February 28, 2026 |
| NCT05786768 | Recruiting | Phase 2/Phase 3 | Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syndrome | October 18, 2023 | December 31, 2027 |
| NCT06065852 | Recruiting | National Registry of Rare Kidney Diseases | November 6, 2009 | December 31, 2039 | |
| NCT04713410 | Unknown status | N/A | Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome | December 22, 2020 | September 4, 2023 |
| NCT04536181 | Withdrawn | Phase 3 | Study of Initial Steroid Treatment in Young Children With Nephrotic Syndrome | January 1, 2021 | October 1, 2022 |